The British Heart Foundation announced the winner of its $36 million Big Beat Challenge, one of the largest non-commercial awards ever given for heart research. The winning team, CureHeart, brings together researchers from the U.K., U.S.
The British Heart Foundation announced the winner of its $36 million Big Beat Challenge, one of the largest non-commercial awards ever given for heart research. The winning team, CureHeart, brings together researchers from the U.K., U.S.
Stem cells sent to space A team of scientists is working on research that is quite literally out of this world. Their ultimate hope is to stop diseases like Parkinsons and multiple sclerosis, and theyre going to incredible lengths to do it. BETHESDA, Md.
Jana K. Dickter, M.D., City of Hope associate clinical professor in the Division of Infectious Diseases City of Hope announced July 27 that a 66-year-old man who was diagnosed with HIV in 1988 has been in remission from the virus for over 17 months after stopping antiretroviral therapy (ART) for the disease following a stem cell transplant from an unrelated donor for acute leukemia. Jana K.
Research led by Muhammad Riaz, PhD, Jinkyu Park, PhD, and Lorenzo Sewanan, MD, PhD, from the Qyang and Campbell laboratories at Yale, provides a mechanism to identify abnormalities linked with a hereditary cardiac condition, hypertrophic cardiomyopathy (HCM), in which walls of the left ventricle become abnormally thick and often stiff.
What if, in people with blinding retinal disorders, one could simply introduce into the retina healthy photoreceptor cells derived in a dish from stem cells, and restore sight?
July 28, 2022 Jai Dwivedi, Ph.D., Assistant Professor and Director of Laboratory Instruction in the Department of Biological Sciences at St. Johns University, has been fascinated by sharks since childhoodand that fascination has led him to research the species for clues to curing two vexing human conditions: Alzheimers and Parkinsons diseases. Its not as far-fetched as it sounds, Dr.
Researchers have revealed the cellular mysteries behind aging.
University of Maryland bioengineers have developed a new technique to capture and analyze circulating tumor cells, one of the primary culprits in metastatic cancer.
WORCESTER, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc.(Mustang) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that the first patient successfully received LV-RAG1 ex vivo lentiviral gene therapy to treat recombinase-activating gene-1 (RAG1) severe combined immunodeficiency (RAG1-SCID), in an ongoing Phase 1/2 multicenter clinical trial taking place in Europe. LV-RAG1 is exclusively licensed by Mustang for the development of MB-110, a first-in-class ex vivo lentiviral gene therapy for the treatment of RAG1-SCID. Patients with SCID have mutations in blood stem cell genes that are responsible for the development and function of infection-fighting immune cells.
DUBLIN, July 25, 2022 /PRNewswire/ -- The 'Global Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western Blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End-user (Pharma, Biotech, CROs), and Region - Forecast to 2027'report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo The global research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility, and increasing R&D expenditure in the life sciences industry
Recent Comments